oxazoles has been researched along with Staphylococcal Infections in 47 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (23.40) | 18.7374 |
1990's | 10 (21.28) | 18.2507 |
2000's | 8 (17.02) | 29.6817 |
2010's | 18 (38.30) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rademacher, J; Welte, T | 1 |
Asai, N; Hagihara, M; Kato, H; Koizumi, Y; Matsuura, K; Mikamo, H; Nishiyama, N; Sakanashi, D; Suematsu, H; Yamagishi, Y | 1 |
Bast, LK; Hennes, E; Krumm, C; Lanfer, F; Richter, L; Schmidt, M; Seymen, R; Tiller, JC | 1 |
Goering, RV; Thomson, KS | 1 |
Bartizal, K; Locke, JB; Shaw, KJ; Zurenko, GE | 1 |
Deane, J; Goering, RV; Jenkins, SG; Locke, JB; Sahm, DF; Scharn, CR; Shaw, KJ; Zuill, DE | 1 |
Fiedler-Kelly, J; Flanagan, S; Lu, Q; Ludwig, E; Passarell, J; Prokocimer, P | 1 |
Martin, CA; Marx, K; Rybak, JM | 1 |
Basuino, L; Chambers, HF; Chan, LC; Dip, EC | 1 |
Ang, W; Chang, Y; Chen, G; Li, G; Liu, Y; Long, H; Luo, Y; Sang, Z; Tang, J; Wang, Z; Wei, Y; Yang, S; Yang, T; Yang, X; Zhang, J | 1 |
Greenwood Quaintance, KE; Karau, MJ; Patel, R; Schmidt-Malan, SM | 1 |
Greenwood-Quaintance, KE; Mandrekar, J; Park, KH; Patel, R | 1 |
Arber, M; Barata, T; Eales, J; Fleetwood, K; Glanville, J; Gould, IM; Kauf, TL; McCool, R | 1 |
Arora, P; Barman, TK; Bhadauriya, T; Rao, M; Upadhyay, DJ | 1 |
Drusano, GL; Kulawy, R; Liu, W; Louie, A | 2 |
Aguiar-Ricardo, A; Bonifácio, VD; Casimiro, T; Correia, VG; da Silva, CL; Moutinho, G; Pinho, MG; Raje, VP | 1 |
Baker, N; Bennett, JM; Berry, J; Collins, I; Czaplewski, LG; Haydon, DJ; Logan, A; Macdonald, R; Macleod, L; Mitchell, JP; Nayal, N; Peasley, H; Srivastava, A; Stokes, NR; Yadav, A | 1 |
Anderegg, TR; Biedenbach, DJ; Jones, RN | 1 |
Appelbaum, PC; Ednie, LM; Hoellman, DB; Jacobs, MR; Lin, G; Rattan, A | 1 |
Colleran, E; Cormican, M; Curtin, J; Fleming, G; Keelehan, J | 1 |
Hashiguchi, S; Iizawa, Y; Ishikawa, T; Miyake, A; Nagai, J; Nakao, M; Okonogi, K | 1 |
Arora, SK; Bhateja, P; Das, B; Malhotra, S; Mathur, T; Mehta, A; Pandya, M; Rao, AV; Rattan, A; Ray, A; Rudra, S; Saini, S; Shukla, S; Soni, A; Srinivas, AS; Yadav, A | 1 |
Andes, D; Craig, WA | 1 |
Greenstein, M; Jacobus, NV; Maiese, WM; Petersen, PJ; Singh, MP; Steinberg, DA | 1 |
Broom, NJ; Elder, JS; Hannan, PC; O'Hanlon, PJ; Pons, JE; Walker, G; Wilson, J; Woodall, P | 1 |
Drenning, SD; Mulazimoglu, L; Yu, VL | 1 |
Batts, DH; Daley-Yates, PT; Pawsey, SD; Schaadt, RD; Stalker, DJ; Zurenko, GE | 1 |
Adamski, JL; Allwine, DA; Barbachyn, MR; Brickner, SJ; Burton, PS; Conradi, RA; Ford, CW; Grega, KC; Hutchinson, DK; Jensen, RM; Klock, JL; Tucker, JA; Zurenko, GE | 1 |
Adams, WJ; Allwine, DA; Emmert, DE; Ford, CW; Friis, JM; Garmon, SA; Genin, MJ; Hamel, JC; Hester, JB; Hutchinson, DK; Schaadt, RD; Shobe, EM; Stapert, D; Yagi, BH; Zurenko, GE | 1 |
Peters, G; von Eiff, C | 1 |
Patel, R; Piper, KE; Rouse, MS; Steckelberg, JM | 1 |
Antony, SJ; Bitter, KM; Diaz-Luna, H; Moreland, T; Raudales, F | 1 |
Chien, JW; Kucia, ML; Salata, RA | 1 |
Weintraub, PM | 1 |
Bevilacqua, R; Oliva, B; Ravagnan, G; Renzini, G | 1 |
Bevilacqua, RL; Ciaffi, G; Ravagnan, L | 1 |
Holstein, PE; Hvid-Hansen, O | 1 |
Bodunkova, LE; Fomina, IP; Kuznetsova, SM; Vasil'ev, VK | 1 |
Smith, LG | 1 |
Matthews, SJ | 1 |
Depp, R; Johnson, WL; Kind, AC; Kirby, WM | 1 |
Leigh, DA; Spencer, R | 1 |
Wiek, K | 1 |
5 review(s) available for oxazoles and Staphylococcal Infections
Article | Year |
---|---|
[New antibiotics - standstill or progress].
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Infections; Ceftaroline; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Drug Approval; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ephedrine; Humans; Macrolides; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Penicillanic Acid; Phenobarbital; Staphylococcal Infections; Tazobactam; Theophylline; Triazoles | 2017 |
Tedizolid for the management of human infections: in vitro characteristics.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Gene Transfer, Horizontal; Humans; Linezolid; Organophosphates; Oxazoles; Oxazolidinones; Point Mutation; Ribosomal Protein L3; Ribosomal Proteins; RNA, Ribosomal, 23S; Staphylococcal Infections; Staphylococcus aureus; tRNA Methyltransferases | 2014 |
Two new drugs for skin and skin structure infections.
Topics: Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Humans; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Staphylococcal Infections; Teicoplanin | 2014 |
Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drugs, Investigational; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Prodrugs; Staphylococcal Infections; Vancomycin-Resistant Enterococci | 2014 |
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.
Topics: Anti-Bacterial Agents; Bayes Theorem; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin | 2017 |
2 trial(s) available for oxazoles and Staphylococcal Infections
Article | Year |
---|---|
Serum inhibitory titers and serum bactericidal titers for human subjects receiving multiple doses of the antibacterial oxazolidinones eperezolid and linezolid.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae | 1997 |
Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Epidural Abscess; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Oxazoles; Oxazolidinones; Parotitis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance | 2000 |
40 other study(ies) available for oxazoles and Staphylococcal Infections
Article | Year |
---|---|
Efficacy of tedizolid against methicillin-resistant Staphylococcus aureus and Peptostreptococcus anaerobius in thigh mixed-infection mouse model.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Female; Gram-Positive Bacterial Infections; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Peptostreptococcus; Staphylococcal Infections; Thigh | 2017 |
Poly(2-oxazoline)-Antibiotic Conjugates with Penicillins.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Stability; Escherichia coli; Escherichia coli Infections; Humans; Hydrolysis; Oxazoles; Penicillinase; Penicillins; Staphylococcal Infections; Staphylococcus aureus | 2017 |
Activity of tedizolid (TR-700) against well-characterized methicillin-resistant Staphylococcus aureus strains of diverse epidemiological origins.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Organophosphates; Oxazoles; Staphylococcal Infections; Tigecycline | 2013 |
Identification and characterization of linezolid-resistant cfr-positive Staphylococcus aureus USA300 isolates from a New York City medical center.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; Clindamycin; Diterpenes; Drug Resistance, Multiple, Bacterial; Gene Transfer Techniques; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Sequence Data; New York; Organophosphates; Oxazoles; Oxazolidinones; Plasmids; Staphylococcal Infections; Thiamphenicol | 2014 |
Tedizolid population pharmacokinetics, exposure response, and target attainment.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Biological Availability; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Neutrophils; Organophosphates; Oxazoles; Oxazolidinones; Platelet Count; Prodrugs; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Young Adult | 2014 |
Comparative efficacies of tedizolid phosphate, vancomycin, and daptomycin in a rabbit model of methicillin-resistant Staphylococcus aureus endocarditis.
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Drug Administration Schedule; Endocarditis; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Rabbits; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2015 |
Discovery of a Teraryl Oxazolidinone Compound (S)-N-((3-(3-Fluoro-4-(4-(pyridin-2-yl)-1H-pyrazol-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide Phosphate as a Novel Antimicrobial Agent with Enhanced Safety Profile and Efficacies.
Topics: Acetamides; Animals; Anti-Infective Agents; Bacteria; Biological Availability; Drug Design; Ether-A-Go-Go Potassium Channels; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Models, Molecular; Oxazoles; Oxazolidinones; Potassium Channel Blockers; Staphylococcal Infections; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles | 2015 |
In vitro activity of tedizolid against staphylococci isolated from prosthetic joint infections.
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Humans; Inhibitory Concentration 50; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus | 2016 |
Activity of Tedizolid in Methicillin-Resistant Staphylococcus aureus Experimental Foreign Body-Associated Osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Bone Wires; Disease Models, Animal; Drug Combinations; Drug Resistance, Bacterial; Foreign Bodies; Injections, Intraperitoneal; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Organophosphates; Osteomyelitis; Oxazoles; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Tibia; Vancomycin | 2016 |
Utilization of Bombyx mori larvae as a surrogate animal model for evaluation of the anti-infective potential of oxazolidinones.
Topics: Animals; Anti-Infective Agents; Bombyx; Disease Models, Animal; Furans; Humans; Larva; Methicillin Resistance; Mice; Oxazoles; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2008 |
In vivo pharmacodynamics of torezolid phosphate (TR-701), a new oxazolidinone antibiotic, against methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains in a mouse thigh infection model.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Female; Humans; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Oxazolidinones; Serum; Staphylococcal Infections; Staphylococcus aureus; Tetrazoles; Thigh | 2011 |
Oxazoline-based antimicrobial oligomers: synthesis by CROP using supercritical CO2.
Topics: Anti-Bacterial Agents; Aziridines; Carbamates; Carbon Dioxide; Escherichia coli; Escherichia coli Infections; Humans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Oxazoles; Polymers; Quaternary Ammonium Compounds; Spectroscopy, Fourier Transform Infrared; Staphylococcal Infections; Staphylococcus aureus | 2011 |
Impact of granulocytes on the antimicrobial effect of tedizolid in a mouse thigh infection model.
Topics: Animals; Anti-Infective Agents; Female; Granulocytes; Mice; Microbial Sensitivity Tests; Models, Theoretical; Organophosphates; Oxazoles; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Tetrazoles; Thigh | 2011 |
An improved small-molecule inhibitor of FtsZ with superior in vitro potency, drug-like properties, and in vivo efficacy.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Bacterial Proteins; Benzamides; Biological Availability; Colony Count, Microbial; Cytokinesis; Cytoskeletal Proteins; Drug Resistance, Multiple, Bacterial; Female; Injections, Intravenous; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Mutation; Oxazoles; Prodrugs; Staphylococcal Infections; Staphylococcus epidermidis; Succinates; Succinic Acid; Thigh; Treatment Outcome | 2013 |
In vitro evaluation of AZD2563, a novel oxazolidinone, against 603 recent staphylococcal isolates.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Humans; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus | 2002 |
Antipneumococcal and antistaphylococcal activities of ranbezolid (RBX 7644), a new oxazolidinone, compared to those of other agents.
Topics: Anti-Bacterial Agents; Culture Media; Furans; Humans; Kinetics; Microbial Sensitivity Tests; Oxazoles; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus; Streptococcus pneumoniae | 2003 |
Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections.
Topics: Acetamides; Anti-Infective Agents; Biofilms; Catheterization, Central Venous; Catheters, Indwelling; Colony Count, Microbial; Gentamicins; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Sodium Chloride; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2003 |
In vitro antimicrobial activity of T-91825, a novel anti-MRSA cephalosporin, and in vivo anti-MRSA activity of its prodrug, TAK-599.
Topics: Animals; Butyrates; Ceftaroline; Cephalosporins; Disease Models, Animal; Enterococcus; Male; Methicillin Resistance; Mice; Mice, Inbred CBA; Mice, Inbred ICR; Microbial Sensitivity Tests; Oxazoles; Pneumonia, Bacterial; Staphylococcal Infections; Staphylococcus | 2004 |
Synthesis and SAR of novel oxazolidinones: discovery of ranbezolid.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Microbial; Furans; Gram-Positive Bacteria; Heterocyclic Compounds; Mice; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcal Infections; Structure-Activity Relationship | 2005 |
Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target.
Topics: Animals; Butyrates; Female; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Oxazoles; Pneumonia, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Thigh | 2006 |
Mechanistic studies and biological activity of bioxalomycin alpha 2, a novel antibiotic produced by Streptomyces viridodiastaticus subsp. "litoralis" LL-31F508.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; DNA, Bacterial; Female; Hydroquinones; Mice; Microbial Sensitivity Tests; Oxazoles; RNA, Bacterial; Staphylococcal Infections; Streptomyces | 1994 |
The chemistry of pseudomonic acid. Part 14. Synthesis and in vivo biological activity of heterocyclyl substituted oxazole derivatives.
Topics: Animals; Anti-Bacterial Agents; Furans; Humans; Isoxazoles; Mice; Mupirocin; Oxazoles; Pyrazoles; Pyridines; Sepsis; Staphylococcal Infections; Thiazoles; Thiophenes | 1995 |
In vitro activities of two novel oxazolidinones (U100592 and U100766), a new fluoroquinolone (trovafloxacin), and dalfopristin-quinupristin against Staphylococcus aureus and Staphylococcus epidermidis.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Synergism; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Naphthyridines; Oxazoles; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Time Factors; Virginiamycin | 1996 |
Piperazinyl oxazolidinone antibacterial agents containing a pyridine, diazene, or triazene heteroaromatic ring.
Topics: Acetamides; Anti-Bacterial Agents; Caco-2 Cells; Enterococcus faecalis; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Permeability; Piperazines; Pyridines; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Structure-Activity Relationship; Triazenes | 1998 |
Nitrogen-carbon-linked (azolylphenyl)oxazolidinones with potent antibacterial activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Haemophilus influenzae; Inhibitory Concentration 50; Injections, Intravenous; Male; Mice; Moraxella catarrhalis; Oxazoles; Pyrazoles; Pyrroles; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Structure-Activity Relationship | 1998 |
Comparative in-vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfopristin and linezolid against staphylococci.
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Fluoroquinolones; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Oxazoles; Oxazolidinones; Quinolines; Staphylococcal Infections; Staphylococcus; Virginiamycin | 1999 |
In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Penicillin Resistance; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin | 1999 |
Methicillin-resistant Staphylococcus aureus infection in a renal allograft recipient treated successfully with a novel new antimicrobial agent (linezolid): new treatment options for infections due to resistant organisms.
Topics: Acetamides; Adult; Anti-Infective Agents; Drug Resistance, Microbial; Humans; Kidney Transplantation; Linezolid; Male; Methicillin Resistance; Oxazoles; Oxazolidinones; Staphylococcal Infections; Transplantation, Homologous | 1999 |
Antibiotic available for compassionate use.
Topics: Acetamides; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Hotlines; Humans; Linezolid; Methicillin Resistance; Oxazoles; Oxazolidinones; Staphylococcal Infections | 1998 |
Heterocycles. 5. Oxazole N-oxides.
Topics: Animals; Chickens; Cyclic N-Oxides; Escherichia coli Infections; Magnetic Resonance Spectroscopy; Mice; Orthomyxoviridae Infections; Oxazoles; Pasteurella Infections; Protozoan Infections; Salmonella Infections, Animal; Staphylococcal Infections; Turkeys | 1972 |
[In vitro and in vivo activity of a new semisynthetic penicillin: flucloxacillin].
Topics: Animals; Bacteria; Dicloxacillin; Fluorine; Mice; Microbial Sensitivity Tests; Oxazoles; Penicillins; Staphylococcal Infections; Staphylococcus; Streptococcal Infections; Streptococcus | 1973 |
[Antistaphylococcal activity of propicillin, oxacillin and dichloxacillin compared with that of penicillin G].
Topics: Animals; Dicloxacillin; Mice; Oxacillin; Oxazoles; Penicillin G; Penicillin V; Penicillins; Staphylococcal Infections; Staphylococcus | 1967 |
[Dicloxacilline (Diclocil) in non-specific ostitis and osteomyelitis].
Topics: Adolescent; Adult; Aged; Child, Preschool; Dicloxacillin; Female; Humans; Male; Middle Aged; Osteitis; Osteomyelitis; Oxazoles; Penicillins; Staphylococcal Infections | 1972 |
[Penicillinase resistant semisynthetic penicillins--antibacterial action and circulatory characteristics of patients' blood].
Topics: Blood Bactericidal Activity; Blood Circulation; Child; Cloxacillin; Depression, Chemical; Dicloxacillin; Humans; Injections, Intramuscular; Methicillin; Oxacillin; Oxazoles; Penicillin G; Penicillin Resistance; Penicillinase; Penicillins; Staphylococcal Infections; Staphylococcus | 1971 |
Chronic staphylococcal infections of bone and soft tissue. Treatment with dicloxacillin.
Topics: Abscess; Adolescent; Adult; Aged; Cellulitis; Child; Chronic Disease; Dicloxacillin; Female; Folliculitis; Furunculosis; Humans; Male; Middle Aged; Osteomyelitis; Oxazoles; Penicillins; Staphylococcal Infections; Ulcer | 1970 |
Dicloxacillin in the treatment of pure staphylococcal and of mixed staphylococcal-streptococcal infections of childhood.
Topics: Child; Child, Preschool; Dicloxacillin; Humans; Infant; Oxazoles; Penicillins; Staphylococcal Infections; Streptococcal Infections | 1970 |
Transplacental passage of methicillin and dicloxacillin into the fetus and amniotic fluid.
Topics: Amniotic Fluid; Dicloxacillin; Female; Fetus; Humans; Maternal-Fetal Exchange; Methicillin; Oxazoles; Penicillins; Pregnancy; Protein Binding; Staphylococcal Infections | 1970 |
Treatment of staphylococcal infections with flucloxacillin.
Topics: Drug Stability; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Oxazoles; Penicillins; Staphylococcal Infections | 1971 |
[Treatment of staphylococcal sepsis with dicloxacillin].
Topics: Dicloxacillin; Humans; Oxazoles; Penicillins; Sepsis; Staphylococcal Infections | 1967 |
Dicloxacillin--a new penicillinase-resistant penicillin.
Topics: Adult; Child; Dicloxacillin; Humans; Oxazoles; Penicillin G; Penicillin Resistance; Penicillinase; Penicillins; Staphylococcal Infections | 1968 |